Injective (INJ) is currently priced at $3.80, reflecting a 4.64% increase over the last 24 hours. The price has fluctuated between $3.63 and $3.89 in this period, indicating a relatively stable daily range of 0.26%, which suggests low volatility.

The trading volume stands at approximately $71.86 million, corresponding to a volume-to-market cap ratio of 18.92%, indicating healthy trading activity relative to its market capitalization. Moving averages show an upward trend with the 21 SMA at $3.76 (+1.19%) and the 55 SMA at $3.60 (+5.45%), signaling potential support levels.

The one-hour RSI is at 55, suggesting that INJ is nearing overbought territory but not yet in that zone, while the 7-day RSI is neutral at 50, indicating no immediate buying or selling pressure. Over the last 30 days, INJ has shown a significant price increase of 38.88%, reinforcing bullish sentiment in the medium term.

The all-time high of $52.62, reached in March 2024, provides a reference point for potential future growth, though the current price remains significantly below that level. Given the recent price action and positive momentum indicators, a consolidation above $3.80 could indicate further upward movement.

Considering the overall analysis, Injective demonstrates a solid short-term bullish trend supported by positive volume and moving averages. Therefore, the rating for Injective (INJ) is a Buy, as the technical indicators and momentum suggest further potential upside in the near term.